apathy; intervention; ecological momentary assessment; timeseries analyses; dynamics; single case
Abstract :
[en] Background: Motivational negative symptoms hinder quality of life and daily functioning of individuals with schizophrenia spectrum disorders. A recently developed intervention, Switch, has shown promising effects on negative symptoms and functional outcomes. Switch targets multiple cognitive, emotional and behavioural processes associated with motivation and goal directed behaviours. We aimed to investigate its effects on motivation and associated processes and explore the dynamics between the processes. Methods: We used a single case approach (n = 3), with a pre-post and follow-up assessment design, which also included ambulatory assessments (experience sampling method, ESM; and step count). We computed autoregressive lag 1 models to evaluate the effects of the intervention on daily motivation levels and related processes, descriptive pie-charts, and vector autoregressive modelling to reveal the dynamics of the processes over time. Results: The intervention was beneficial for each participant according to traditional evaluations of motivational negative symptoms, apathy, daily functioning and quality of life. The effects on the ESM variables revealed distinct outcomes for each individual. The dynamics between the various processes differed between participants, and fluctuated within participants (when comparing baseline, intervention phase, and follow-up). Conclusions: This study used an innovative approach to look at the efficacy of an intervention. The intervention seems to lead to significant improvements. The mechanisms of change need to be further investigated.
Disciplines :
Treatment & clinical psychology
Author, co-author :
Thonon, Bénédicte ; Université de Liège - ULiège > Département de Psychologie > Département de Psychologie
Van Aubel, Evelyne; KU Leuven > Department of Neurosciences > Center for Contextual Psychiatry
Lafit, Ginette; KU Leuven > Department of Neurosciences > Center for Contextual Psychiatry
Della Libera, Clara ; Université de Liège - ULiège > Département de Psychologie > Psychologie clinique cognitive et comportementale
Laroi, Frank ; Université de Liège - ULiège > Département de Psychologie > Département de Psychologie
Language :
English
Title :
Idiographic analyses of motivation and related processes in participants with schizophrenia following a therapeutic intervention for negative symptoms
Sauvé G, Brodeur MB, Shah JL, Lepage M. The prevalence of negative symptoms across the stages of the psychosis continuum. Harv Rev Psychiatry. 2019;27:15-32. https://doi.org/10.1097/HRP.0000000000000184.
Strauss GP, Horan WP, Kirkpatrick B, Fischer BA, Keller WR, Miski P, et al. Deconstructing negative symptoms of schizophrenia: Avolition-apathy and diminished expression clusters predict clinical presentation and functional outcome. J Psychiatr Res. 2013;47:783-90. https://doi.org/10.1016/j.jpsychires.2013.01.015.
Horan WP, Kring AM, Gur RE, Reise SP, Blanchard JJ. Development and psychometric validation of the clinical assessment interview for negative symptoms (CAINS). Schizophr Res. 2011.
Beck AT, Himelstein R, Bredemeier K, Silverstein SM, Grant P. What accounts for poor functioning in people with schizophrenia: a re-evaluation of the contributions of neurocognitive v. attitudinal and motivational factors. Psychol Med. 2018;48:2776-85. https://doi.org/10.1017/S0033291718000442.
Fervaha G, Foussias G, Agid O, Remington G. Motivational deficits in early schizophrenia: prevalent, persistent, and key determinants of functional outcome. Schizophr Res. 2015;166:9-16.
Savill M, Orfanos S, Reininghaus U, Wykes T, Bentall R, Priebe S. The relationship between experiential deficits of negative symptoms and subjective quality of life in schizophrenia. Schizophr Res. 2016;176:387-91. https://doi.org/10.1016/j.schres.2016.06.017.
Lutgens D, Gariepy G, Malla A. Psychological and psychosocial interventions for negative symptoms in psychosis: systematic review and meta-analysis. Br J Psychiatry. 2017;210:324-32.
Fusar-Poli P, Papanastasiou E, Stahl D, Rocchetti M, Carpenter W, Shergill S, et al. Treatments of negative symptoms in schizophrenia: meta-analysis of 168 randomized placebo-controlled trials. Schizophr Bull. 2015;41:892-9. https://doi.org/10.1093/schbul/sbu170.
Thonon B, Levaux M, Della Libera C, Larøi F. Switch, a new intervention that targets motivational negative symptoms in people with schizophrenia: an uncontrolled pilot study. Journal of Clinical Psychology. 2020;jclp.22963. https://doi.org/10.1002/jclp.22963.
Kring AM, Barch DM. The motivation and pleasure dimension of negative symptoms: neural substrates and behavioral outputs. Eur Neuropsychopharmacol. 2014;24:725-36. https://doi.org/10.1016/j.euroneuro.2013.06.007.
Farquharson L, MacLeod AK. A brief goal-setting and planning intervention to improve well-being for people with psychiatric disorders. Psychother Psychosom. 2014;83:122-4.
Renner F, Ji JL, Pictet A, Holmes EA, Blackwell SE. Effects of engaging in repeated mental imagery of future positive events on Behavioural activation in individuals with major depressive disorder. Cognit Ther Res. 2017;41:369-80.
Gollwitzer PM, Sheeran P. Implementation intentions and goal achievement: a meta-analysis of effects and processes. In: Advances in Experimental Social Psychology; 2006. p. 69-119. https://doi.org/10.1016/S0065-2601(06)38002-1.
Favrod J, Nguyen A, Chaix J, Pellet J, Frobert L, Fankhauser C, et al. Improving pleasure and motivation in schizophrenia: a randomized controlled clinical trial. Psychother Psychosom. 2019;88:84-95. https://doi.org/10.1159/000496479.
Hayes SC, Pistorello J, Levin ME. Acceptance and commitment therapy as a unified model of behavior change. Couns Psychol. 2012;40:976-1002. https://doi.org/10.1177/0011000012460836.
Granholm E, Holden J, Link PC, McQuaid JR. Randomized clinical trial of cognitive behavioral social skills training for schizophrenia: improvement in functioning and experiential negative symptoms. J Consult Clin Psychol. 2014;82:1173-85. https://doi.org/10.1037/a0037098.
Anthony WA. Recovery from mental illness: The guiding vision of the mental health service system in the 1990s. Psychosoc Rehabil J. 1993.
Bentley KH, Kleiman EM, Elliott G, Huffman JC, Nock MK. Real-time monitoring technology in single-case experimental design research: opportunities and challenges. Behav Res Ther. 2019.
Myin-Germeys I, Kasanova Z, Vaessen T, Vachon H, Kirtley O, Viechtbauer W, et al. Experience sampling methodology in mental health research: new insights and technical developments. World Psychiatry. 2018;17:123-32. https://doi.org/10.1002/wps.20513.
Myin-Germeys I, Oorschot M, Collip D, Lataster J, Delespaul P. Van Os. Experience sampling research in psychopathology: opening the black box of daily life. Psychol Med. 2009;39:1533-47. https://doi.org/10.1017/S0033291708004947.
Teicher MH. Actigraphy and motion analysis: new tools for psychiatry. Harv Rev Psychiatry. 1995;3:18-35.
Shiffman S, Stone AA, Hufford MR. Ecological Momentary Assessment. Annu Rev Clin Psychol. 2008.
Kluge A, Kirschner M, Hager OM, Bischof M, Habermeyer B, Seifritz E, et al. Combining actigraphy, ecological momentary assessment and neuroimaging to study apathy in patients with schizophrenia. Schizophr Res. 2018;195:176-82. https://doi.org/10.1016/j.schres.2017.09.034.
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (5th Edition). 2013.
Kaup AR, Dunn LB, Saks ER, Jeste DV, Palmer BW. Decisional capacity and consent for schizophrenia research. IRB Ethics Hum Res. 2011;33:1-9.
Gardner DM, Murphy AL, O'Donnell H, Centorrino F, Baldessarini RJ. International consensus study of antipsychotic dosing. Am J Psychiatry. 2010;167:686-93. https://doi.org/10.1176/appi.ajp.2009.09060802.
Kirkpatrick B, Strauss GP, Nguyen L, Fischer BA, Daniel DG, Cienfuegos A, et al. The brief negative symptom scale: psychometric properties. Schizophr Bull. 2011;37:300-5.
Mucci A, Vignapiano A, Bitter I, Austin SF, Delouche C, Dollfus S, et al. A large European, multicenter, multinational validation study of the brief negative symptom scale. Eur Neuropsychopharmacol. 2019;29:947-59. https://doi.org/10.1016/j.euroneuro.2019.05.006.
Kirkpatrick B, Saoud JB, Strauss GP, Ahmed AO, Tatsumi K, Opler M, et al. The brief negative symptom scale (BNSS): sensitivity to treatment effects. Schizophr Res. 2018.
Sockeel P, Dujardin K, Devos D, Denève C, Destée A, Defebvre L. The Lille apathy rating scale (LARS), a new instrument for detecting and quantifying apathy: validation in Parkinson's disease. J Neurol Neurosurg Psychiatry. 2006;77:579-84.
Yazbek H, Norton J, Capdevielle D, Larue A, Boulenger JP, Gély-Nargeot MC, et al. The Lille apathy rating scale (LARS): exploring its psychometric properties in schizophrenia. Schizophr Res. 2014;157:278-84. https://doi.org/10.1016/j.schres.2014.04.034.
Auquier P, Simeoni MC, Sapin C, Reine G, Aghababian V, Cramer J, et al. Development and validation of a patient-based health-related quality of life questionnaire in schizophrenia: the S-QoL. Schizophr Res. 2003;63:137-49. https://doi.org/10.1016/S0920-9964(02)00355-9.
Lançon C, Reine G, Simeoni MC, Aghababian V, Auquier P. Développement et validation d'un instrument d'auto-évaluation de la qualité de vie des patients souffrant de schizophrénie: La S-QoL. Encephale. 2007.
Dujardin K, Sockeel P, Delliaux M, Destée A, Defebvre L. The Lille apathy rating scale: validation of a caregiver-based version. Mov Disord. 2008;23:845-9.
Llorca P-M, Lançon C, Lancrenon S, Bayle F-J, Caci H, Rouillon F, et al. The "functional remission of general schizophrenia" (FROGS) scale: development and validation of a new questionnaire. Schizophr Res. 2009;113:218-25. https://doi.org/10.1016/j.schres.2009.04.029.
Boyer L, Richieri R, Guedj E, Faget-Agius C, Loundou A, Llorca PM, et al. Validation of a functional remission threshold for the functional remission of general schizophrenia (FROGS) scale. Compr Psychiatry. 2013;54:1016-22. https://doi.org/10.1016/j.comppsych.2013.04.008.
Kimhy D, Myin-Germeys I, Palmier-Claus J, Swendsen J. Mobile assessment guide for research in schizophrenia and severe mental disorders. Schizophr Bull. 2012;38(3):386.
Epskamp S, van Borkulo CD, van der Veen DC, Servaas MN, Isvoranu AM, Riese H, et al. Personalized network modeling in psychopathology: the importance of contemporaneous and temporal connections. Clin Psychol Sci. 2018;6(3):416.
Epskamp S, Cramer AOJ, Waldorp LJ, Schmittmann VD, Borsboom D. Qgraph: Network visualizations of relationships in psychometric data. J Stat Softw; 2012.
Ruwaard J, Kooistra L, Thong M. Ecological momentary assessment in mental Health Research: a practical introduction, with examples in R. 2018. http://blog.jruwaard.nl/ema-in-mental-health-research/. Accessed 15 Feb 2020.
van Aubel E, Bakker JM, Batink T, Michielse S, Goossens L, Lange I, et al. Blended care in the treatment of subthreshold symptoms of depression and psychosis in emerging adults: a randomised controlled trial of acceptance and commitment therapy in daily-life (ACT-DL). Behav Res Ther. 2020;128:103592. https://doi.org/10.1016/j.brat.2020.103592.
Widdershoven RLA, Wichers M, Kuppens P, Hartmann JA, Menne-Lothmann C, CJP S, et al. Effect of self-monitoring through experience sampling on emotion differentiation in depression. J Affect Disord. 2019;244:71.
Robinaugh DJ, Hoekstra RHA, Toner ER, Borsboom D. The network approach to psychopathology: a review of the literature 2008-2018 and an agenda for future research. Psychol Med. 2020;50:353-66. https://doi.org/10.1017/S0033291719003404.
Li Z, Yin M, Lyu X-L, Zhang L-L, Du X-D, Hung GC-L. Delayed effect of repetitive transcranial magnetic stimulation (rTMS) on negative symptoms of schizophrenia: findings from a randomized controlled trial. Psychiatry Res. 2016;240:333-5. https://doi.org/10.1016/j.psychres.2016.04.046.
Aleman A, Lincoln TM, Bruggeman R, Melle I, Arends J, Arango C, et al. Treatment of negative symptoms: where do we stand, and where do we go? Schizophr Res. 2017;186:55-62. https://doi.org/10.1016/j.schres.2016.05.015.
Levinson CA, Vanzhula I, Brosof LC. Longitudinal and personalized networks of eating disorder cognitions and behaviors: targets for precision intervention a proof of concept study. Int J Eat Disord. 2018;51:1233-43. https://doi.org/10.1002/eat.22952.
Bell IH, Lim MH, Rossell SL, Thomas N. Ecological momentary assessment and intervention in the treatment of psychotic disorders: a systematic review. Psychiatr Serv. 2017;68:1172-81. https://doi.org/10.1176/appi.ps.201600523.
Kramer I, Simons CJP, Hartmann JA, Menne-Lothmann C, Viechtbauer W, Peeters F, et al. A therapeutic application of the experience sampling method in the treatment of depression: a randomized controlled trial. World Psychiatry. 2014;13:68-77. https://doi.org/10.1002/wps.20090.
